quinoxalines has been researched along with rosiglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ledford, H | 1 |
| Feng, D; Li, Y; Liu, D; Ning, S; Sun, R; Tian, D; Tian, X; Wang, Z; Yao, J; Zhang, F; Zhao, Y | 1 |
2 other study(ies) available for quinoxalines and rosiglitazone
| Article | Year |
|---|---|
Drug safety crackdown revs up.
Topics: Benzazepines; Female; Humans; Male; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration; Varenicline; Violence | 2010 |
Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Coenzyme A Ligases; DNA-Binding Proteins; Ferroptosis; Humans; Intestines; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Models, Animal; Promoter Regions, Genetic; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Rosiglitazone; Sp1 Transcription Factor; Spiro Compounds | 2019 |